Diversification of NAD biological role: The importance of location

FEBS Journal

Volumn 280, Issue 19, 2013, Pages 4711-4728

  Di Stefano, Michele ^a   Conforti, Laura ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

ARTs; NAD; NAD biological functions; NAD biosynthesis; NAD degradation; NAMPT; NMNAT; Sirtuins; subcellular compartments

Indexed keywords

DINUCLEOTIDE; MONONUCLEOTIDE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE RIBOSIDE; NICOTINIC ACID; NUCLEOTIDE; QUINOLINIC ACID; SIRTUIN 1; UNCLASSIFIED DRUG;

BIODIVERSITY; BIOLOGICAL FUNCTIONS; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; CIRCADIAN RHYTHM; CYTOPLASM; DEGRADATION; HUMAN; MITOCHONDRION; NERVE FIBER DEGENERATION; NONHUMAN; NUCLEIC ACID STRUCTURE; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ARTS; NAD; NAD BIOLOGICAL FUNCTIONS; NAD BIOSYNTHESIS; NAD DEGRADATION; NAMPT; NMNAT; SIRTUINS; SUBCELLULAR COMPARTMENTS;

ANIMALS; HUMANS; NAD; SIRTUINS;

EID: 84884596730     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12433     Document Type: Review

References (180)

1. Berger F, Ramirez-Hernandez MH, &, Ziegler M, (2004) The new life of a centenarian: signalling functions of NAD(P). Trends Biochem Sci 29, 111-118.
2. +-dependent tubulin deacetylase. Mol Cell 11, 437-444.
3. Ueda K, &, Hayaishi O, (1985) ADP-ribosylation. Annu Rev Biochem 54, 73-100.
4. Hayaishi O, &, Ueda K, (1977) Poly(ADP-ribose) and ADP-ribosylation of proteins. Annu Rev Biochem 46, 95-116.
5. Clapper DL, Walseth TF, Dargie PJ, &, Lee HC, (1987) Pyridine nucleotide metabolites stimulate calcium release from sea urchin egg microsomes desensitized to inositol trisphosphate. J Biol Chem 262, 9561-9568.
6. +-dependent signalling. FEBS Lett 585, 1651-1656.
7. + in fungi and humans. Cell 117, 495-502.
8. + homeostasis in man. Cell Mol Life Sci 61, 19-34.
9. Nikiforov A, Dolle C, Niere M, &, Ziegler M, (2011) Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem 286, 21767-21778.
10. Revollo JR, Grimm AA, &, Imai S, (2004) The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279, 50754-50763.
11. Shibata K, Hayakawa T, &, Iwai K, (1986) Tissue distribution of the enzymes concerned with the biosynthesis of NAD in rats. Agric Biol Chem 50, 3037-3041.
12. Hara N, Yamada K, Shibata T, Osago H, Hashimoto T, &, Tsuchiya M, (2007) Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. J Biol Chem 282, 24574-24582.
13. + and poly(ADP-ribose) levels but do not affect diethylnitrosamine-induced altered hepatic foci in Fischer-344 rats. J Nutr 125, 1455-1461.
14. Handler P, &, Kohn HI, (1943) The mechanisms of cozymase synthesis in the human erythrocyte: a comparison of the roles of nicotinic acid and nicotinamide. J Biol Chem 150, 447-452.
15. + levels dictate cell survival. Cell 130, 1095-1107.
16. Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA, &, Sartorelli V, (2008) Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 14, 661-673.
17. Gross CJ, &, Henderson LM, (1983) Digestion and absorption of NAD by the small intestine of the rat. J Nutr 113, 412-420.
18. Revollo JR, Korner A, Mills KF, Satoh A, Wang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, Townsend RR, et al,. (2007) Nampt/PBEF/Visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme. Cell Metab 6, 363-375.
19. Hinsch N, Frank M, Doring C, Vorlander C, &, Hansmann ML, (2009) QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study. BMC Cancer 9, 93.
20. Foster AC, &, Schwarcz R, (1985) Characterization of quinolinic acid phosphoribosyltransferase in human blood and observations in Huntington's disease. J Neurochem 45, 199-205.
21. Terakata M, Fukuwatari T, Sano M, Nakao N, Sasaki R, Fukuoka S, &, Shibata K, (2012) Establishment of true niacin deficiency in quinolinic acid phosphoribosyltransferase knockout mice. J Nutr 142, 2148-2153.
22. Rongvaux A, Andris F, Van Gool F, &, Leo O, (2003) Reconstructing eukaryotic NAD metabolism. BioEssays 25, 683-690.
23. Dietrich LS, Muniz O, &, Powanda M, (1968) NAD synthesis in animal tissues. J Vitaminol 14 (Suppl), 123-129.
24. Galassi L, Di Stefano M, Brunetti L, Orsomando G, Amici A, Ruggieri S, &, Magni G, (2012) Characterization of human nicotinate phosphoribosyltransferase: kinetic studies, structure prediction and functional analysis by site-directed mutagenesis. Biochimie 94, 300-309.
25. Hagino Y, Lan SJ, Ng CY, &, Henderson LM, (1968) Metabolism of pyridinium precursors of pyridine nucleotides in perfused rat liver. J Biol Chem 243, 4980-4986.
26. Ijichi H, Ichiyama A, &, Hayaishi O, (1966) Studies on the biosynthesis of nicotinamide adenine dinucleotide. 3. Comparative in vivo studies on nicotinic acid, nicotinamide, and quinolinic acid as precursors of nicotinamide adenine dinucleotide. J Biol Chem 241, 3701-3707.
27. +. PLoS Biol 5, e263.
28. + precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 15, 838-847.
29. + biosynthesis. Biochemistry 46, 4912-4922.
30. Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, &, Ruggieri S, (2004) Structure and function of nicotinamide mononucleotide adenylyltransferase. Curr Med Chem 11, 873-885.
31. Berger F, Lau C, Dahlmann M, &, Ziegler M, (2005) Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem 280, 36334-36341.
32. Emanuelli M, Carnevali F, Saccucci F, Pierella F, Amici A, Raffaelli N, &, Magni G, (2001) Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase. J Biol Chem 276, 406-412.
33. Garavaglia S, D'Angelo I, Emanuelli M, Carnevali F, Pierella F, Magni G, &, Rizzi M, (2002) Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis. J Biol Chem 277, 8524-8530.
34. s) mouse. Gene 284, 23-29.
35. Raffaelli N, Sorci L, Amici A, Emanuelli M, Mazzola F, &, Magni G, (2002) Identification of a novel human nicotinamide mononucleotide adenylyltransferase. Biochem Biophys Res Commun 297, 835-840.
36. Sood R, Bonner TI, Makalowska I, Stephan DA, Robbins CM, Connors TD, Morgenbesser SD, Su K, Faruque MU, Pinkett H, et al,. (2001) Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus. Genomics 73, 211-222.
37. Yalowitz JA, Xiao S, Biju MP, Antony AC, Cummings OW, Deeg MA, &, Jayaram HN, (2004) Characterization of human brain nicotinamide 5′-mononucleotide adenylyltransferase-2 and expression in human pancreas. Biochem J 377, 317-326.
38. Mayer PR, Huang N, Dewey CM, Dries DR, Zhang H, &, Yu G, (2010) Expression, localization, and biochemical characterization of nicotinamide mononucleotide adenylyltransferase 2. J Biol Chem 285, 40387-40396.
39. Ljungberg MC, Ali YO, Zhu J, Wu CS, Oka K, Zhai RG, &, Lu HC, (2012) CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy. Hum Mol Genet 21, 251-267.
40. Di Stefano M, Galassi L, &, Magni G, (2010) Unique expression pattern of human nicotinamide mononucleotide adenylyltransferase isozymes in red blood cells. Blood Cells Mol Dis 45, 33-39.
41. Zhang X, Kurnasov OV, Karthikeyan S, Grishin NV, Osterman AL, &, Zhang H, (2003) Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J Biol Chem 278, 13503-13511.
42. Werner E, Ziegler M, Lerner F, Schweiger M, &, Heinemann U, (2002) Crystal structure of human nicotinamide mononucleotide adenylyltransferase in complex with NMN. FEBS Lett 516, 239-244.
43. Zhou T, Kurnasov O, Tomchick DR, Binns DD, Grishin NV, Marquez VE, Osterman AL, &, Zhang H, (2002) Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin. J Biol Chem 277, 13148-13154.
44. Brunetti L, Di Stefano M, Ruggieri S, Cimadamore F, &, Magni G, (2010) Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: new insights on structure and function relationship. Protein Sci 19, 2440-2450.
45. Magni G, Di Stefano M, Orsomando G, Raffaelli N, &, Ruggieri S, (2009) NAD(P) biosynthesis enzymes as potential targets for selective drug design. Curr Med Chem 16, 1372-1390.
46. Lau C, Dolle C, Gossmann TI, Agledal L, Niere M, &, Ziegler M, (2010) Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyltransferases. J Biol Chem 285, 18868-18876.
47. Okazaki IJ, &, Moss J, (1996) Structure and function of eukaryotic mono-ADP-ribosyltransferases. Rev Physiol Biochem Pharmacol 129, 51-104.
48. Corda D, &, Di Girolamo M, (2003) Functional aspects of protein mono-ADP-ribosylation. EMBO J 22, 1953-1958.
49. Smith S, (2001) The world according to PARP. Trends Biochem Sci 26, 174-179.
50. Hassa PO, &, Hottiger MO, (2008) The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 13, 3046-3082.
51. Althaus FR, (1992) Poly ADP-ribosylation: a histone shuttle mechanism in DNA excision repair. J Cell Sci 102, 663-670.
52. Sauve AA, (2010) Sirtuin chemical mechanisms. Biochim Biophys Acta 1804, 1591-1603.
53. Guarente L, (2000) Sir2 links chromatin silencing, metabolism, and aging. Genes Dev 14, 1021-1026.
54. Imai S, &, Guarente L, (2010) Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 31, 212-220.
55. Canto C, Sauve AA, &, Bai P, (2013) Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Aspects Med. doi: 10.1016/j.mam.2013.01.004.
56. Sauve AA, Wolberger C, Schramm VL, &, Boeke JD, (2006) The biochemistry of sirtuins. Annu Rev Biochem 75, 435-465.
57. Tong L, &, Denu JM, (2010) Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose. Biochim Biophys Acta 1804, 1617-1625.
58. +-dependent auto-ADP-ribosylation. Biochem J 318, 903-908.
59. O'Reilly T, &, Niven DF, (2003) Levels of nicotinamide adenine dinucleotide in extracellular body fluids of pigs may be growth-limiting for Actinobacillus pleuropneumoniae and Haemophilus parasuis. Can J Vet Res 67, 229-231.
60. + transport across cell membranes. FASEB J 13, 273-283.
61. + surfaces again. Biochem J 382, e5-e6.
62. Billington RA, Bruzzone S, De Flora A, Genazzani AA, Koch-Nolte F, Ziegler M, &, Zocchi E, (2006) Emerging functions of extracellular pyridine nucleotides. Mol Med 12, 324-327.
63. Durnin L, Dai Y, Aiba I, Shuttleworth CW, Yamboliev IA, &, Mutafova-Yambolieva VN, (2012) Release, neuronal effects and removal of extracellular β-nicotinamide adenine dinucleotide (β-NAD) in the rat brain. Eur J Neurosci 35, 423-435.
64. + fluxes in intact cells. FASEB J 15, 10-12.
65. + release and P2Y11-mediated signaling. Stem Cells Dev 20, 1183-1198.
66. + regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J Immunol 175, 3075-3083.
67. + regulates intracellular free calcium concentration in human monocytes. Biochem J 382, 849-856.
68. Kawamura H, Aswad F, Minagawa M, Malone K, Kaslow H, Koch-Nolte F, Schott WH, Leiter EH, &, Dennert G, (2005) P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide. J Immunol 174, 1971-1979.
69. +. J Physiol 590, 1921-1941.
70. Yamboliev IA, Smyth LM, Durnin L, Dai Y, &, Mutafova-Yambolieva VN, (2009) Storage and secretion of β-NAD, ATP and dopamine in NGF-differentiated rat pheochromocytoma PC12 cells. Eur J Neurosci 30, 756-768.
71. Zimmermann H, (1996) Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog Neurobiol 49, 589-618.
72. Deaglio S, &, Robson SC, (2011) Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol 61, 301-332.
73. Ortolan E, Vacca P, Capobianco A, Armando E, Crivellin F, Horenstein A, &, Malavasi F, (2002) CD157, the Janus of CD38 but with a unique personality. Cell Biochem Funct 20, 309-322.
74. Funaro A, De Monte LB, Dianzani U, Forni M, &, Malavasi F, (1993) Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur J Immunol 23, 2407-2411.
75. Di Girolamo M, Dani N, Stilla A, &, Corda D, (2005) Physiological relevance of the endogenous mono(ADP-ribosyl)ation of cellular proteins. FEBS J 272, 4565-4575.
76. Seman M, Adriouch S, Haag F, &, Koch-Nolte F, (2004) Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signaling. Curr Med Chem 11, 857-872.
77. Evans WH, Hood DO, &, Gurd JW, (1973) Purification and properties of a mouse liver plasma-membrane glycoprotein hydrolysing nucleotide pyrophosphate and phosphodiester bonds. Biochem J 135, 819-826.
78. Garavaglia S, Bruzzone S, Cassani C, Canella L, Allegrone G, Sturla L, Mannino E, Millo E, De Flora A, &, Rizzi M, (2012) The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism. Biochem J 441, 131-141.
79. Gustafsson AJ, Muraro L, Dahlberg C, Migaud M, Chevallier O, Khanh HN, Krishnan K, Li N, &, Islam MS, (2010) ADP ribose is an endogenous ligand for the purinergic P2Y1 receptor. Mol Cell Endocrinol 333, 8-19.
80. Zhou HH, Chin CN, Wu M, Ni W, Quan S, Liu F, Dallas-Yang Q, Ellsworth K, Ho T, Zhang A, et al,. (2009) Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. Eur J Pharmacol 616, 346-352.
81. Chin CN, Dallas-Yang Q, Liu F, Ho T, Ellsworth K, Fischer P, Natasha T, Ireland C, Lu P, Li C, et al,. (2009) Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity. Eur J Pharmacol 606, 17-24.
82. +: a modulator of immune functions. Innate Immun 17, 212-233.
83. Luk T, Malam Z, &, Marshall JC, (2008) Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 83, 804-816.
84. Imai S, (2009) Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr Pharm Des 15, 20-28.
85. Samal B, Sun Y, Stearns G, Xie C, Suggs S, &, McNiece I, (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14, 1431-1437.
86. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O, &, Andris F, (2002) Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 32, 3225-3234.
87. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, &, Marshall JC, (2004) Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113, 1318-1327.
88. Li Y, Zhang Y, Dorweiler B, Cui D, Wang T, Woo CW, Brunkan CS, Wolberger C, Imai S, &, Tabas I, (2008) Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J Biol Chem 283, 34833-34843.
89. Romacho T, Azcutia V, Vazquez-Bella M, Matesanz N, Cercas E, Nevado J, Carraro R, Rodriguez-Manas L, Sanchez-Ferrer CF, &, Peiro C, (2009) Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity. Diabetologia 52, 2455-2463.
90. Fan Y, Meng S, Wang Y, Cao J, &, Wang C, (2011) Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway. Int J Mol Med 27, 607-615.
91. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, et al,. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426-430.
92. + intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 14, 528-536.
93. Caton PW, Kieswich J, Yaqoob MM, Holness MJ, &, Sugden MC, (2011) Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function. Diabetologia 54, 3083-3092.
94. Adya R, Tan BK, Chen J, &, Randeva HS, (2009) Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis. Atherosclerosis 205, 113-119.
95. Hara N, Yamada K, Shibata T, Osago H, &, Tsuchiya M, (2011) Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma. PLoS One 6, e22781.
96. + salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem 284, 20408-20417.
97. + synthase. J Biol Chem 287, 12405-12416.
98. Berger F, Lau C, &, Ziegler M, (2007) Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1. Proc Natl Acad Sci USA 104, 3765-3770.
99. + synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. FEBS J 278, 2666-2679.
100. Chiang PW, Wang J, Chen Y, Fu Q, Zhong J, Chen Y, Yi X, Wu R, Gan H, Shi Y, et al,. (2012) Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis. Nat Genet 44, 972-974.
101. Falk MJ, Zhang Q, Nakamaru-Ogiso E, Kannabiran C, Fonseca-Kelly Z, Chakarova C, Audo I, Mackay DS, Zeitz C, Borman AD, et al,. (2012) NMNAT1 mutations cause Leber congenital amaurosis. Nat Genet 44, 1040-1045.
102. Koenekoop RK, Wang H, Majewski J, Wang X, Lopez I, Ren H, Chen Y, Li Y, Fishman GA, Genead M, et al,. (2012) Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration. Nat Genet 44, 1035-1039.
103. Perrault I, Hanein S, Zanlonghi X, Serre V, Nicouleau M, Defoort-Delhemmes S, Delphin N, Fares-Taie L, Gerber S, Xerri O, et al,. (2012) Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy. Nat Genet 44, 975-977.
104. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, &, Chua KF, (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100, 10794-10799.
105. Kummar S, Chen A, Parchment RE, Kinders RJ, Ji J, Tomaszewski JE, &, Doroshow JH, (2012) Advances in using PARP inhibitors to treat cancer. BMC Med 10, 25.
106. Hassa PO, Haenni SS, Elser M, &, Hottiger MO, (2006) Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70, 789-829.
107. Chiarugi A, (2002) Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited. Trends Pharmacol Sci 23, 122-129.
108. Zerfaoui M, Errami Y, Naura AS, Suzuki Y, Kim H, Ju J, Liu T, Hans CP, Kim JG, Abd Elmageed ZY, et al,. (2010) Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-κB upon TLR4 stimulation. J Immunol 185, 1894-1902.
109. Hinz M, Stilmann M, Arslan SC, Khanna KK, Dittmar G, &, Scheidereit C, (2010) A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation. Mol Cell 40, 63-74.
110. Koh DW, Dawson TM, &, Dawson VL, (2005) Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res 52, 5-14.
111. + depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. J Neurosci 30, 2967-2978.
112. Cen Y, Youn DY, &, Sauve AA, (2011) Advances in characterization of human sirtuin isoforms: chemistries, targets and therapeutic applications. Curr Med Chem 18, 1919-1935.
113. Guarente L, &, Picard F, (2005) Calorie restriction-the SIR2 connection. Cell 120, 473-482.
114. Burnett C, Valentini S, Cabreiro F, Goss M, Somogyvari M, Piper MD, Hoddinott M, Sutphin GL, Leko V, McElwee JJ, et al,. (2011) Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477, 482-485.
115. Imai S, Johnson FB, Marciniak RA, McVey M, Park PU, &, Guarente L, (2000) Sir2: an NAD-dependent histone deacetylase that connects chromatin silencing, metabolism, and aging. Cold Spring Harb Symp Quant Biol 65, 297-302.
116. Boily G, Seifert EL, Bevilacqua L, He XH, Sabourin G, Estey C, Moffat C, Crawford S, Saliba S, Jardine K, et al,. (2008) SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 3, e1759.
117. Sequeira J, Boily G, Bazinet S, Saliba S, He X, Jardine K, Kennedy C, Staines W, Rousseaux C, Mueller R, et al,. (2008) sirt1-null mice develop an autoimmune-like condition. Exp Cell Res 314, 3069-3074.
118. Knight JR, &, Milner J, (2012) SIRT1, metabolism and cancer. Curr Opin Oncol 24, 68-75.
119. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, et al,. (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26, 3169-3179.
120. Min SW, Cho SH, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, Huang EJ, Shen Y, Masliah E, Mukherjee C, et al,. (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67, 953-966.
121. van der Veer E, Ho C, O'Neil C, Barbosa N, Scott R, Cregan SP, &, Pickering JG, (2007) Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J Biol Chem 282, 10841-10845.
122. Wang P, Xu TY, Guan YF, Tian WW, Viollet B, Rui YC, Zhai QW, Su DF, &, Miao CY, (2011) Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol 69, 360-374.
123. Anderson RM, Bitterman KJ, Wood JG, Medvedik O, &, Sinclair DA, (2003) Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423, 181-185.
124. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F, Mostoslavsky R, Alt FW, &, Schibler U, (2008) SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134, 317-328.
125. +-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134, 329-340.
126. + biosynthesis. Science 324, 651-654.
127. + salvage pathway by CLOCK-SIRT1. Science 324, 654-657.
128. Asher G, Reinke H, Altmeyer M, Gutierrez-Arcelus M, Hottiger MO, &, Schibler U, (2010) Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding. Cell 142, 943-953.
129. + oscillation. Aging 3, 794-802.
130. Peek CB, Ramsey KM, Marcheva B, &, Bass J, (2012) Nutrient sensing and the circadian clock. Trends Endocrinol Metab 23, 312-318.
131. + carrier proteins. J Biol Chem 284, 31249-31259.
132. + transporter in Saccharomyces cerevisiae. J Biol Chem 281, 1524-1531.
133. Nakagawa T, Lomb DJ, Haigis MC, &, Guarente L, (2009) SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560-570.
134. Pittelli M, Formentini L, Faraco G, Lapucci A, Rapizzi E, Cialdai F, Romano G, Moneti G, Moroni F, &, Chiarugi A, (2010) Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool. J Biol Chem 285, 34106-34114.
135. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, &, Steegborn C, (2008) Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 382, 790-801.
136. Hirschey MD, Shimazu T, Huang JY, &, Verdin E, (2009) Acetylation of mitochondrial proteins. Methods Enzymol 457, 137-147.
137. Huang JY, Hirschey MD, Shimazu T, Ho L, &, Verdin E, (2010) Mitochondrial sirtuins. Biochim Biophys Acta 1804, 1645-1651.
138. Sack MN, (2011) Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart. Am J Physiol 301, H2191-H2197.
139. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, et al,. (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125.
140. Hallows WC, Lee S, &, Denu JM, (2006) Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci USA 103, 10230-10235.
141. Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos GD, Karow M, Blander G, et al,. (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic β cells. Cell 126, 941-954.
142. Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, Aouizerat B, Stancakova A, Goetzman E, Lam MM, Schwer B, et al,. (2011) SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 44, 177-190.
143. Choi MM, Huh JW, Yang SJ, Cho EH, Choi SY, &, Cho SW, (2005) Identification of ADP-ribosylation site in human glutamate dehydrogenase isozymes. FEBS Lett 579, 4125-4130.
144. + depletion and cell death induced by oxidative stress. J Biol Chem 278, 18426-18433.
145. Druzhyna N, Smulson ME, LeDoux SP, &, Wilson GL, (2000) Poly(ADP-ribose) polymerase facilitates the repair of N-methylpurines in mitochondrial DNA. Diabetes 49, 1849-1855.
146. Lai Y, Chen Y, Watkins SC, Nathaniel PD, Guo F, Kochanek PM, Jenkins LW, Szabo C, &, Clark RS, (2008) Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury. J Neurochem 104, 1700-1711.
147. Pankotai E, Lacza Z, Muranyi M, &, Szabo C, (2009) Intra-mitochondrial poly(ADP-ribosyl)ation: potential role for α-ketoglutarate dehydrogenase. Mitochondrion 9, 159-164.
148. Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L, Wang J, Sastre M, Ono K, Sauve AA, et al,. (2013) Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol Aging 34, 1581-1588.
149. 2+ release in sea urchin egg homogenates: modulation by cyclic ADP-ribose. Science 253, 1143-1146.
150. Lee HC, &, Aarhus R, (1995) A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose. J Biol Chem 270, 2152-2157.
151. Albrieux M, Lee HC, &, Villaz M, (1998) Calcium signaling by cyclic ADP-ribose, NAADP, and inositol trisphosphate are involved in distinct functions in ascidian oocytes. J Biol Chem 273, 14566-14574.
152. Kristian T, Balan I, Schuh R, &, Onken M, (2011) Mitochondrial dysfunction and nicotinamide dinucleotide catabolism as mechanisms of cell death and promising targets for neuroprotection. J Neurosci Res 89, 1946-1955.
153. Maxwell MM, Tomkinson EM, Nobles J, Wizeman JW, Amore AM, Quinti L, Chopra V, Hersch SM, &, Kazantsev AG, (2011) The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet 20, 3986-3996.
154. Smith S, Giriat I, Schmitt A, &, de Lange T, (1998) Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282, 1484-1487.
155. Chi NW, &, Lodish HF, (2000) Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles. J Biol Chem 275, 38437-38444.
156. Milde S, Gilley J, &, Coleman MP, (2013) Subcellular localization determines the stability and axon protective capacity of axon survival factor nmnat2. PLoS Biol 11, e1001539.
157. Gilley J, &, Coleman MP, (2010) Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 8, e1000300.
158. Stoll G, Jander S, &, Myers RR, (2002) Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J Peripher Nerv Syst 7, 13-27.
159. Lunn ER, Perry VH, Brown MC, Rosen H, &, Gordon S, (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1, 27-33.
160. s) mouse. Proc Natl Acad Sci USA 95, 9985-9990.
161. S) mouse. Proc Natl Acad Sci USA 97, 11377-11382.
162. Conforti L, Wilbrey A, Morreale G, Janeckova L, Beirowski B, Adalbert R, Mazzola F, Di Stefano M, Hartley R, Babetto E, et al,. (2009) Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol 184, 491-500.
163. S determines its neuroprotective efficacy for axons and synapses in vivo. J Neurosci 29, 653-668.
164. Babetto E, Beirowski B, Janeckova L, Brown R, Gilley J, Thomson D, Ribchester RR, &, Coleman MP, (2010) Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo. J Neurosci 30, 13291-13304.
165. Babetto E, Beirowski B, Russler EV, Milbrandt J, &, Diantonio A, (2013) The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction. Cell Rep 3, 1422-1429.
166. Xiong X, Hao Y, Sun K, Li J, Li X, Mishra B, Soppina P, Wu C, Hume RI, &, Collins CA, (2012) The Highwire ubiquitin ligase promotes axonal degeneration by tuning levels of Nmnat protein. PLoS Biol 10, e1001440.
167. Hicks AN, Lorenzetti D, Gilley J, Lu B, Andersson KE, Miligan C, Overbeek PA, Oppenheim R, &, Bishop CE, (2012) Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) regulates axon integrity in the mouse embryo. PLoS One 7, e47869.
168. S to delay Wallerian degeneration. Cell Death Differ 14, 116-127.
169. Araki T, Sasaki Y, &, Milbrandt J, (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010-1013.
170. Wang J, Zhai Q, Chen Y, Lin E, Gu W, McBurney MW, &, He Z, (2005) A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol 170, 349-355.
171. Sasaki Y, Araki T, &, Milbrandt J, (2006) Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J Neurosci 26, 8484-8491.
172. Sasaki Y, Vohra BP, Lund FE, &, Milbrandt J, (2009) Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J Neurosci 29, 5525-5535.
173. +-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119, 803-814.
174. Jayaram HN, Kusumanchi P, &, Yalowitz JA, (2011) NMNAT expression and its relation to NAD metabolism. Curr Med Chem 18, 1962-1972.
175. +-dependent protein deacetylase, via activation of PPARα in mice. Mol Cell Biochem 339, 285-292.
176. Rajamohan SB, Pillai VB, Gupta M, Sundaresan NR, Birukov KG, Samant S, Hottiger MO, &, Gupta MP, (2009) SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Mol Cell Biol 29, 4116-4129.
177. + metabolism and signaling to the control of cellular functions. Biochim Biophys Acta 1804, 1666-1675.
178. + depletion and reduced Sir2α deacetylase activity. J Biol Chem 280, 43121-43130.
179. Barbosa MT, Soares SM, Novak CM, Sinclair D, Levine JA, Aksoy P, &, Chini EN, (2007) The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J 21, 3629-3639.
180. Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, et al,. (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13, 461-468.